PDCD1 and Miyoshi myopathy: The presence of a high CD8+ T/Treg cell ratio predicting ICB responsiveness in only 14% of MM cases may provide a scientific rationale to the negative results of the anti-PD-1 monoclonal antibody in past clinical trials15,16,39.